We are live on
!
Find out more
BC
Blackhill Capital Portfolio holdings
AUM
$1.94B
1-Year Est. Return
18.09%
This Fund
S&P 500
This Quarter
Est. Return
-5.91%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$1.61B
AUM Growth
-$129M
(-7.4%)
Cap. Flow
-$6.79M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
92.66%
Holding
53
New
–
Increased
2
Reduced
5
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.05M |
| 2 |
Tootsie Roll Industries
TR
|
+$1.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$5.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.47M |
| 3 |
Eli Lilly
LLY
|
+$160K |
| 4 |
Williams-Sonoma
WSM
|
+$71.5K |
| 5 |
Zimmer Biomet
ZBH
|
+$29.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 68.66% |
| 2 | Healthcare | 19.37% |
| 3 | Technology | 6.58% |
| 4 | Financials | 1.31% |
| 5 | Industrials | 1.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Williams-Sonoma
WSM
$29.5B
| $1.1B | 68.37% |
7,808,428
-480
| -0% | -$71.5K |
|
|
2
Eli Lilly
LLY
$1.08T
| $133M | 8.26% |
147,198
-200
| -0.1% | -$160K |
|
3
Apple
AAPL
$4.45T
| $55.1M | 3.41% |
261,400
| – | – |
|
|
4
AbbVie
ABBV
$442B
| $46.1M | 2.86% |
268,810
+18,400
| +7% | +$3.05M |
|
5
Microsoft
MSFT
$3.74T
| $32.2M | 2% |
72,050
| – | – |
|
6
Abbott
ABT
$190B
| $31M | 1.92% |
298,230
| – | – |
|
7
Merck
MRK
$322B
| $25.8M | 1.6% |
208,500
| – | – |
|
8
Zoetis
ZTS
$31.1B
| $25.4M | 1.58% |
146,499
| – | – |
|
9
Johnson & Johnson
JNJ
$626B
| $23M | 1.43% |
157,238
| – | – |
|
10
Caterpillar
CAT
$388B
| $20M | 1.24% |
60,000
| – | – |
|
11
NVIDIA
NVDA
$5.27T
| $17.1M | 1.06% |
138,500
| – | – |
|
12
Walt Disney
DIS
$179B
| $10.1M | 0.63% |
101,500
| – | – |
|
|
13
Zimmer Biomet
ZBH
$18.5B
| $8.98M | 0.56% |
82,700
-250
| -0.3% | -$29.5K |
|
|
14
Bristol-Myers Squibb
BMY
$130B
| $8.91M | 0.55% |
214,464
-100,000
| -32% | -$4.47M |
|
15
Mastercard
MA
$492B
| $8.82M | 0.55% |
20,000
| – | – |
|
16
Berkshire Hathaway Class B
BRK.B
$1.11T
| $8.64M | 0.54% |
21,244
| – | – |
|
17
Kimberly-Clark
KMB
$36.1B
| $7.46M | 0.46% |
54,000
| – | – |
|
18
Procter & Gamble
PG
$338B
| $7.4M | 0.46% |
44,871
| – | – |
|
19
Cigna
CI
$72.4B
| $7.2M | 0.45% |
21,779
| – | – |
|
20
Amazon
AMZN
$2.94T
| $3.88M | 0.24% |
20,100
| – | – |
|
|
21
Berkshire Hathaway Class A
BRK.A
$1.11T
| $3.67M | 0.23% |
6
| – | – |
|
|
22
Kenvue
KVUE
$36.6B
| $3.3M | 0.2% |
181,516
-263,371
| -59% | -$5.1M |
|
23
Alphabet (Google) Class C
GOOG
$4.19T
| $3.24M | 0.2% |
17,660
| – | – |
|
24
Enterprise Products Partners
EPD
$81.8B
| $3.15M | 0.2% |
108,704
| – | – |
|
|
25
Alphabet (Google) Class A
GOOGL
$4.2T
| $2.91M | 0.18% |
15,980
| – | – |
|
Similar funds
FFH
OCM
AAA
FC
HC
NIM
CC
DCM
Blackhill Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Blackhill Capital held 53 positions worth $1.61B, down 7.4% from $1.74B the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Trading was light in Q2 2024: portfolio turnover was 0%. Blackhill Capital opened no new positions and made no exits, leaving the 53-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 69% of assets, down from 71% a quarter earlier, followed by Healthcare and Technology.
- Blackhill Capital added most to AbbVie in Q2 2024, an estimated $3.05M increase.
- Blackhill Capital's biggest Q2 2024 reduction was Kenvue, cutting an estimated $5.1M.
- Blackhill Capital's ten largest holdings make up 93% of its $1.61B portfolio in Q2 2024.
- Blackhill Capital opened 0 new positions and closed 0 in Q2 2024.
- Blackhill Capital's portfolio value fell 7.4% quarter-over-quarter to $1.61B.
Based on Blackhill Capital's 13F filing for Q2 2024, filed 13 Aug 2024.